Trident Lifeline Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹48.41 crore, reflecting a quarter-on-quarter *(QoQ) increase of 88.29 per cent from ₹25.71 crore. This corresponds to a year-on-year *(YoY) growth of 42.34 per cent.
Operating Profit
Operating Profit stands at ₹11.06 crore, reflecting a quarter-on-quarter *(QoQ) increase of 117.29 per cent from ₹5.09 crore. This corresponds to a year-on-year *(YoY) growth of 29.66 per cent.
PBDT
PBDT stands at ₹11.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 40.73 per cent from ₹8.47 crore. This corresponds to a year-on-year *(YoY) growth of 34.54 per cent.
Profit Before Tax
Profit Before Tax stands at ₹10.69 crore, reflecting a quarter-on-quarter *(QoQ) increase of 77.87 per cent from ₹6.01 crore. This corresponds to a year-on-year *(YoY) growth of 74.67 per cent.
Net Profit
Net Profit stands at ₹6.87 crore, reflecting a quarter-on-quarter *(QoQ) increase of 48.06 per cent from ₹4.64 crore. This represents a 11.89 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Trident Lifeline Ltd Earnings
- YOY
- QOQ
Trident Lifeline Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Trident Lifeline Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Trident Lifeline Ltd Financial Reports
Trident Lifeline Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Trident Lifeline | -0.44% | -1.74% | 1.30% | -1.93% | -16.69% | -11.67% |
| Astal Lab | -1.01% | -4.85% | 20.50% | -3.59% | -10.39% | -6.46% |
| Bafna Pharma. | -0.07% | 0.22% | 4.38% | 20.26% | -15.93% | 86.26% |
| Aptus Pharma | -1.89% | -1.89% | 24.32% | 77.00% | 180.18% | 434.77% |
| Gennex Lab. | 3.20% | 18.70% | 7.72% | -3.58% | -18.53% | -13.81% |
| Kerala Ayurveda | 4.93% | 1.60% | -14.08% | -6.95% | -40.08% | -47.97% |
| Zenotech Lab. | 1.03% | -1.44% | -5.64% | -6.18% | -8.33% | -30.12% |
Company Info
Company Information
Chairman/ED & CEO : Hardik J Desai
ED / MD / Promoter : Shravan Harikrishna Patel
Non-Exec & Non-Independent Dir : Maniya H Desai
Independent Non Exe. Director : Mishal Shailesh Patel
Independent Non Exe. Director : Falguni Bhavesh Jariwala
Whole-time Director : Rupaben Chetanbhai Jariwala
Director & CFO : ASHISH ANANDSINGH BAFNA
Company Sec. & Compli. Officer : Nikita Sharma